[Neurostimulation system for cluster headache]

Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
Record ID 32015000953
German
Authors' objectives: Custer headache (CH) is a primary headache disorder, which is characterised by mainly short-term, recurrent, severe unilateral pain with accompanying autonomic symptoms. A small amount of cluster headache patients (1 %), especially those with chronic cluster headache (CCH) is therapy-resistant. The stimulation of the Sphenopalatine Ganglion (SPG), besides various invasive and minimally invasive operative procedures, is a new treatment method for these patients. The aim of our systematic review is to compare the efficacy and safety of the SPG stimulation of patients with therapy-resistant cluster headache with no treatment.
Authors' recommendations: The available evidence is not sufficient to demonstrate superiority of the SPG stimulation for patients with therapy-resistant cluster headache compared to no treatment. New studies may have an impact on the estimate of effect. We propose a re-evaluation when further results from RCTs are available (probably in 2019). At present, the inclusion of SPG stimulation into the hospital benefit catalogue is not recommended.
Details
Project Status: Completed
Year Published: 2015
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Austria
MeSH Terms
  • Cluster Headache
  • Deep Brain Stimulation
  • Hypothalamus
Contact
Organisation Name: Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address: Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name: tarquin.mittermayr@aihta.at
Contact Email: office@aihta.at
Copyright: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.